ArticleJournal of the Egyptian National Cancer Institute2023

Ligand-based drug design of quinazolin-4(3H)-ones as breast cancer inhibitors using QSAR modeling, molecular docking, and pharmacological profiling.

Sagiru Hamza Abdullahi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.